Immunologic characterization of pyruvate kinase from Ehrlich-ascite tumor cells
Grundmann, G.; Schulz, J.; Hofmann, E.
Acta Biologica et Medica Germanica 31(5): 719-725
1973
ISSN/ISBN: 0001-5318 PMID: 4133598 Document Number: 69598
Document emailed within 1 workday
Related Documents
Mukherjee, K.; Ghosh, S.; Ray, M.; Ray, S. 2002: Purification and characterization of 3-phosphoglycerate kinase from Ehrlich ascites carcinoma cells Indian Journal of Biochemistry and Biophysics 39(5): 332-341Mosin, A.F.; Gabał, V.L.; Makarova, I.M.; Mosina, V.A. 1997: Specificity of morphological changes and DNA degradation in the Ehrlich ascite carcinoma cells exposed to various damaging agents Tsitologiia 39(2-3): 209-217
Gumińska, M.; Ignacak, J.; Kedryna, T.; Stachurska, M.B. 1997: Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells Acta Biochimica Polonica 44(4): 711-724
Gumińska, M.; Wazewska-Czyzewska, M. 1980: Effect of Magnesium Diasporal on erythrocyte pyruvate kinase activity in healthy persons and in patients with pyruvate kinase deficiency Folia Medica Cracoviensia 22(3-4): 425-433
Katz, J.; Brand, K.; Golden, S.; Rubinstein, D. 1974: Lactate and pyruvate metabolism and reducing equivalent transfer in Ehrlich ascites tumor Cancer Research 34(4): 872-877
Oremek, G.M.; Teigelkamp, S.; Kramer, W.; Eigenbrodt, E.; Usadel, K.H. 1999: The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma Anticancer Research 19(4a): 2599-2601
Oremek, G.M.; Rutner, F.; Sapoutzis, N.; Sauer-Eppel, H. 2003: Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy Anticancer Research 23(2a): 1155-1158
Hardt, P.D.; Ngoumou, B.K.; Rupp, J.; Schnell-Kretschmer, H.; Kloer, H.U. 2000: Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer Anticancer Research 20(6d): 4965-4968
Strumilo, S.A.; Senkevich, S.B.; Vinogradov, V.V. 1981: Characterization of the kinase activity of bovine adrenal pyruvate dehydrogenase complex Biokhimiia 46(6): 974-978
Heinrichs, M.; Jacobasch, G.; Scheiner-Bobis, K.; Bertram, S.; Eigenbrodt, E.; Reinacher, M. 1987: Human erythrocyte pyruvate kinase (L'/R-PK): production and characterization of a monoclonal antibody Biomedica Biochimica Acta 46(2-3): S223-S228
Abdullah, M.; Rani, A.A.; Simadibrata, M.; Fauzi, A.; Syam, A.F. 2012: The value of fecal tumor M2 pyruvate kinase as a diagnostic tool for colorectal cancer screening Acta Medica Indonesiana 44(2): 94-99
Nomiya, B.; Kagino, K.; Orikasa, Y.; Fujimori, H. 1970: Experimental studies on antineoplastic activity of daunomycin. II. Effect of ascite tumor cells in vivo Japanese Journal of Antibiotics 23(2): 181-188
Cheng, N.; Payne, R.C.; Kemp, W.E.; Traut, T.W. 1986: Homogeneous uridine kinase from Ehrlich ascites tumor: substrate specificity and inhibition by bisubstrate analogs Molecular Pharmacology 30(2): 159-163
Tzanev, D.; Schulz, J.; Jacobasch, G.; Richter, A.; Gerth, C. 1980: Identification of pyruvate kinase variants from red blood cells using trypsinization and electrophoresis Acta Biologica et Medica Germanica 39(7): 745-761
Cerwenka, H.; Aigner, R.; Bacher, H.; Werkgartner, G.; el-Shabrawi, A.; Quehenberger, F.; Mischinger, H.J. 1999: TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions Anticancer Research 19(1b): 849-851
Zardi, L.; Cecconi, C.; Barbieri, O.; Carnemolla, B.; Picca, M.; Santi, L. 1979: Concentration of fibronectin in plasma of tumor-bearing mice and synthesis by Ehrlich ascites tumor cells Cancer Research 39(9): 3774-3779
Matsak, N.I.; Romanov, I.A.; Antokhin, A.I. 1983: Comparative study of the action of an inhibitor and a stimulator present in Ehrlich ascites tumor cells on cell proliferation in the tumor Biulleten' Eksperimental'noi Biologii i Meditsiny 96(12): 74-76
Presek, P.; Glossmann, H.; Eigenbrodt, E.; Schoner, W.; Rübsamen, H.; Friis, R.R.; Bauer, H. 1980: Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3':5'-monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2 Cancer Research 40(5): 1733-1741
Jacobasch, G.; Schulz, J.; Zanev, D.; Richter, A.; Gerth, C.; Plonka, A. 1981: Identification of mutants of pyruvate kinase from red blood cells by means of trypsinization, electrophoresis, kinetic properties and immunological methods Acta Biologica et Medica Germanica 40(4-5): 547-553
Schulze, W.; Horn, G. 1970: Correlations between chemical structure and biological activity of azomethines with nitrogen-mustard-groups on Ehrlich ascites tumor in albino mice. 3. Activation of N-mustard-azomethines by cells of Ehrlich ascites carcinoma Arzneimittel-Forschung 20(3): 329-335